Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2941 to 2955 of 8314 results

  1. Diabetes: annual blood pressure (children)

    This indicator has been updated and replaced by NICE indicator 302 and NICE indicator 303.

  2. Diabetes: annual HbA1c (children)

    This indicator has been updated and replaced by NICE indicator 298 and NICE indicator 299.

  3. Diabetes: annual care processes (children)

    This indicator has been updated and replaced by NICE indicator 296 and NICE indicator 297.

  4. Alcohol use: brief intervention for people with a long-term condition (IND202)

    This indicator covers the percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia with a FAST score of 3 or more or AUDIT-C score of 5 or more in the preceding 2 years who have received brief intervention to help them reduce their alcohol related risk within 3 months of the score being recorded. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM181

  5. Alcohol use: risk assessment for people with a long-term condition (IND201)

    This indicator covers the percentage of patients with 1 or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia who have been screened for hazardous drinking using the FAST or AUDIT-C tool in the preceding 2 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM180

  6. Atrial fibrillation: review of anticoagulation (IND169)

    This indicator covers the percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12 months which included: assessment of stroke/VTE risk; assessment of bleeding risk; assessment of renal function, creatinine clearance, FBC and LFTs as appropriate for their anticoagulation therapy; any adverse effects related to anticoagulation; assessment of compliance; choice of anticoagulant. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM147

  7. Diabetes: annual psychological assessment (children T2DM) (IND314)

    This indicator covers the proportion of children and young people aged under 18 years with type 2 diabetes who have received a psychological assessment in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  8. Diabetes: annual psychological assessment (children T1DM) (IND313)

    This indicator covers the proportion of children and young people aged under 18 years with type 1 diabetes who have received a psychological assessment in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  9. Diabetes: thyroid disease screening (children T1DM) (IND312)

    This indicator covers the proportion of children and young people aged under 18 years with type 1 diabetes who have been screened for thyroid disease in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  10. Diabetes: annual smoking status (children T2DM) (IND311)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 2 diabetes who have had their smoking status recorded in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  11. Diabetes: annual smoking status (children T1DM) (IND310)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 1 diabetes who have had their smoking status recorded in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  12. Diabetes: annual foot examination (children T2DM) (IND309)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 2 diabetes who have a record of a foot examination in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  13. Diabetes: annual foot examination (children T1DM) (IND308)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 1 diabetes who have a record of a foot examination in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  14. Diabetes: eye screening (children T2DM) (IND307)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 2 diabetes who have a record of eye screening in the previous 24 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

  15. Diabetes: eye screening (children T1DM) (IND306)

    This indicator covers the proportion of children and young people aged 12 to 18 years with type 1 diabetes who have a record of eye screening in the previous 24 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes